Načítá se...
It’s time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer
The peritoneal spread of ovarian cancer makes it a potential target for hyperthermic intraperitoneal chemotherapy (HIPEC). Intraperitoneal delivery exposes the tumor to concentrations of cytotoxic drugs much greater than with intravenous delivery, and in vitro studies have also shown that combining...
Uloženo v:
| Vydáno v: | Gynecol Oncol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684262/ https://ncbi.nlm.nih.gov/pubmed/30249527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.09.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|